Hanmi Pharm Co Ltd
KRX:128940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hanmi Pharm Co Ltd
KRX:128940
|
KR |
|
P
|
Polskie Towarzystwo Wspierania Przedsiebiorczosci SA
WSE:PTW
|
PL |
|
Inaba Seisakusho Co Ltd
TSE:3421
|
JP |
|
C
|
CJ Bioscience Inc
KOSDAQ:311690
|
KR |
|
Cognex Corp
NASDAQ:CGNX
|
US |
|
Infragreen Group Ltd
ASX:IFN
|
AU |
Wall Street
Price Targets
Price Targets Summary
Hanmi Pharm Co Ltd
According to Wall Street analysts, the average 1-year price target for
Hanmi Pharm Co Ltd
is 614 353.85 KRW
with a low forecast of 414 100 KRW and a high forecast of 756 000 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hanmi Pharm Co Ltd's stock price target?
Price Target
614 353.85
KRW
According to Wall Street analysts, the average 1-year price target for
Hanmi Pharm Co Ltd
is 614 353.85 KRW
with a low forecast of 414 100 KRW and a high forecast of 756 000 KRW.
What is Hanmi Pharm Co Ltd's Revenue forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Hanmi Pharm Co Ltd's revenue is
7%.
The projected
CAGR
for the next 3 years is
9%.
What is Hanmi Pharm Co Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Hanmi Pharm Co Ltd's operating income is
20%.
The projected
CAGR
for the next 3 years is
16%.
What is Hanmi Pharm Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 14 years the
compound annual growth rate for
Hanmi Pharm Co Ltd's net income is
42%.
The projected
CAGR
for the next 3 years is
21%.
